|
|
Investments in affiliates |
|
Investments in associates |
|
Investments in joint ventures |
|
Other investments and shares in companies |
|
Securities |
|
Loans |
|
Advance payments |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross carrying amount |
|
14.3 |
|
109.6 |
|
3.8 |
|
55.0 |
|
2.1 |
|
17.9 |
|
0.1 |
|
202.8 |
Accumulated depreciation/revaluation |
|
–6.0 |
|
–0.4 |
|
0.0 |
|
–17.0 |
|
0.3 |
|
–0.7 |
|
0.0 |
|
–23.8 |
Carrying amount as of April 1, 2017 |
|
8.3 |
|
109.2 |
|
3.8 |
|
38.0 |
|
2.4 |
|
17.2 |
|
0.1 |
|
179.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross carrying amount |
|
14.1 |
|
114.4 |
|
4.6 |
|
47.9 |
|
1.1 |
|
6.7 |
|
0.2 |
|
189.0 |
Accumulated depreciation/revaluation |
|
–6.5 |
|
–0.5 |
|
0.0 |
|
–12.0 |
|
0.3 |
|
–0.7 |
|
0.0 |
|
–19.4 |
Carrying amount as of March 31, 2018 |
|
7.6 |
|
113.9 |
|
4.6 |
|
35.9 |
|
1.4 |
|
6.0 |
|
0.2 |
|
169.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross carrying amount |
|
23.4 |
|
120.5 |
|
4.5 |
|
47.9 |
|
0.9 |
|
2.7 |
|
0.2 |
|
200.1 |
Accumulated depreciation/revaluation |
|
–12.4 |
|
–0.7 |
|
0.0 |
|
–11.9 |
|
0.3 |
|
–0.5 |
|
0.0 |
|
–25.2 |
Carrying amount as of March 31, 2019 |
|
11.0 |
|
119.8 |
|
4.5 |
|
36.0 |
|
1.2 |
|
2.2 |
|
0.2 |
|
174.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In millions of euros |
||||||||||||||||
The following table shows the reconciliation of the carrying amounts of investments in entities consolidated according to the equity method, other financial assets, and other shares in companies for the periods presented in the Consolidated Financial Statements as of March 31, 2019:
|
|
Investments in affiliates |
|
Investments in associates |
|
Investments in joint ventures |
|
Other investments and shares in companies |
|
Securities |
|
Loans |
|
Advance payments |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying amount as of |
|
8.3 |
|
109.2 |
|
3.8 |
|
38.0 |
|
2.4 |
|
17.2 |
|
0.1 |
|
179.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in the scope of Consolidated Financial Statements |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
Additions |
|
0.1 |
|
14.3 |
|
0.9 |
|
0.0 |
|
0.0 |
|
0.1 |
|
0.1 |
|
15.5 |
Transfers |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
–0.1 |
|
0.0 |
|
–0.1 |
Disposals |
|
–0.3 |
|
–8.1 |
|
0.0 |
|
–2.1 |
|
–1.1 |
|
–11.1 |
|
0.0 |
|
–22.7 |
Depreciation/impairment |
|
–0.5 |
|
–0.1 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
–0.6 |
Revaluation |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.1 |
|
0.0 |
|
0.0 |
|
0.1 |
Net exchange differences |
|
0.0 |
|
–1.4 |
|
–0.2 |
|
0.0 |
|
0.0 |
|
–0.1 |
|
0.0 |
|
–1.7 |
Carrying amount as of |
|
7.6 |
|
113.9 |
|
4.6 |
|
35.9 |
|
1.4 |
|
6.0 |
|
0.2 |
|
169.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in the scope of Consolidated Financial Statements |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
Additions |
|
0.4 |
|
13.3 |
|
0.8 |
|
0.0 |
|
0.0 |
|
0.5 |
|
0.0 |
|
15.0 |
Transfers |
|
3.3 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
–0.1 |
|
0.0 |
|
3.2 |
Disposals |
|
–0.3 |
|
–8.3 |
|
–1.0 |
|
0.0 |
|
–0.2 |
|
–4.2 |
|
0.0 |
|
–14.0 |
Depreciation/impairment |
|
0.0 |
|
–0.1 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
–0.1 |
Revaluation |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.1 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.1 |
Net exchange differences |
|
0.0 |
|
1.0 |
|
0.1 |
|
0.0 |
|
0.0 |
|
0.0 |
|
0.0 |
|
1.1 |
Carrying amount as of |
|
11.0 |
|
119.8 |
|
4.5 |
|
36.0 |
|
1.2 |
|
2.2 |
|
0.2 |
|
174.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In millions of euros |
||||||||||||||||
Loans granted comprise the following items:
|
|
03/31/2017 |
|
03/31/2018 |
|
03/31/2019 |
|
|
|
|
|
|
|
Loans to affiliates |
|
0.5 |
|
0.3 |
|
0.1 |
Other loans |
|
10.9 |
|
5.3 |
|
2.0 |
Other receivables from financing |
|
5.8 |
|
0.4 |
|
0.1 |
|
|
17.2 |
|
6.0 |
|
2.2 |
|
|
|
|
|
|
|
In millions of euros |
||||||